Synthesis, anticonvulsant activity and comparative QSAR study of some novel 1,2,5-trisubstituted benzimidazole derivatives

Acta Pharmaceutica Sciencia

Volumn 52, Issue 4, 2010, Pages 510-521

  Singh, Jitender ^a   Grover, Parul ^a   Pathak, Dharam Pal ^b  

^a Lord Shiva Charitable Trust Sirsa   (India)

^b DELHI INSTITUTE OF PHARMACEUTICAL SCIENCES AND RESEARCH   (India)

Author keywords

Anti convulsant activity; QSAR; Substituted benzimidazoles; Synthesis

Indexed keywords

BENZIMIDAZOLE DERIVATIVE; PHENOBARBITAL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CONVULSION; DRUG MECHANISM; DRUG SCREENING; DRUG SYNTHESIS; MOUSE; NONHUMAN; PHYSICAL CHEMISTRY; QUANTITATIVE STRUCTURE ACTIVITY RELATION;

EID: 79952283904     PISSN: 13072080     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Arpaci, O.T. (2001). QSARs of some 5- or 6- methyl-2-substituted benzooxazoles/benzimidazoles against Candida albicans. Turk. J. Med Sci. 31: 493-497.
2. Bali, A., Bansal, Y., Sugumaram, M., Singh, J.S., Balakumar, P., Kaur, G., Bansal, G., Sharma, A. and Singh, M. (2005). Design, synthesis & evaluation of novelly substituted benzimidazole compounds as angiotensin II receptor antagonists. Biorg. Med. Chem. Lett. 15: 3962-3965.
3. Dhir, A. and Kulkarni S.K. (2006). Rofecoxib, a selective cyclooxygenase-2 (COX-2) inhibitor potentiates the anticonvulsant activity of tiagabine against pentylenetetrazol-induced convulsions in mice. Inflammopharmacology. 14: 222-5
4. Galvao, P.A.A. and Castro, I.O. (1977). The effect of 1-β-D-ribofuranosyl-1,2,4-triazole-3carboxamide in acute viral hepatitis. Ann. N.Y. Acad. Sci. 284: 278-283.
5. Hamor, G.H. (1986). Principles of Medicinal Chemistry. 3rd ed, Foye W.O., Varghese Publishing House, Bombay. pp. 503.
6. Hunger, A. and Kebrle, J. (1957). Synthesis of analgesically active benzimidazole with basic substitution. J Experientia. 13: 400.
7. Jerchee, D. and Leibigs, F.H. (1952). Zur Darstellung Der Benzimidazole. Annalen Chemie. 573: 162-173.
8. Kholer, P. (2001). The biochemical basis of anthelmintic action & resistance. Int. J. Parasitol. 31: 336.
9. Levin, J.I. and Venkatesan, A.M. (1994). Preparation of 3-tetrazolyl biphenylmethyl-4-quinozalinones as angiotensin II antagonists. Chem. Abstr. 120: 323589.
10. Lindberg, P. and Nordberg, P. (1986). The mechanism of action of the antisecretory agent omeprazole. J. Med Chem. 29: 1327-1329.
11. Mishra, M., Srivastava, S.K. and Srivastava, S.D. (1997). Synthesis of some novel 4-thiazolidine analogs. Ind. J. Chem. Sect. B. 36: 826.
12. Pandey, V.K., Gupta, V.D. and Tiwari, D.N. (2004). Synthesis of substituted benzoxazines as potential antiviral agents. Indian J. Hetero. Chem. 13: 399-400.
13. Rayemakers, A.H.M., Freyne, E.J.E. and Sanz, G.C. (1988). Novel (1H-imidazol-1-yl-meyhyl) substituted benzimidazole derivatives. Chem. Abstr. 109: 73437.
14. Rober, D.A., Pearce, R.J. and Bradhury, R.H. (1992). Preparation of 4-[(tetrazolylphenyl)methyl] naphthridines & analogues as angiotensin II antagonists. Chem Abstr. 117: 111587a.
15. Saggu, J. S., Sharma, R., Dureja, H. and Kumar, V. (2002). Benzimidazoles with biphenyls: Synthesis of 5-substituted-2-n-propyl-1-[(2'-carboxybiphenyl-4-yl)-methyl]-benzimidazole. J. Indian Inst. Sci. 82: 177-182.